In this article, senior partner Judi Abbott Curry reviews, analyzes and shares potential implications for future life science cases based on several key judicial holdings in New York in 2022. From pharmaceuticals to toothpaste, preemption to public health, New York state and federal courts issued decisions in 2022 that further shaped the landscape in the medical and life sciences legal world. To prepare the best product liability and class action defense strategies for pharmaceuticals, medical devices, personal care and other FDA regulated products, Judi steps back and reviews holdings that affected the industry and may shape the years ahead.

Read the Rochester Business Journal article here (subscription required) or click here for Judi’s complete year in review.